ABSTRACT
The absence of reported adverse reactions and bacterial resistance to polyhexanide 28 makes it an excellent choice as topical antiseptic. In the present study we evaluated the and burn wounds, and is proposed as an alternative to topical antibiotic treatment (7, 8 (Table 2) .
124
To identify genomic changes associated with antiseptic/antibiotic reduced- (Table 1) in all strains displaying polyhexanide 145 resistance, it seems likely that these mutations are responsible for resistance. MIC 7 determination was also assessed in strains harboring mprFC884T identified in a 147 different experimental context (23). This mutation leading to daptomycin resistance was 148 responsible for a 2-fold factor increase in polihexanide (from 4 to 8 µg/ml). Note that 149 we tried several times but we failed to transfer individual mutation into the parental 150 strain COL, by transduction using several staphylococcal phages. 
190
In the present study, we provide evidence that prolonged in vitro exposure to low bacteria/ml. After incubation for 2 days at 37¡C, bacteria growing at concentration of 316 polyhexanide 0.5 or 1 µg/ml, were used for a second step passage in increased 317 polyhexanide concentrations. Further stepwise passages were done when indicated.
318
After passages bacteria were collected and macrodilution MIC was determined. An were tested using disc diffusion assays according to EUCAST methods. 
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